Literature DB >> 7822283

Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1).

A Kovoor1, D J Henry, C Chavkin.   

Abstract

In Xenopus oocytes expressing the rat mu receptor and the G protein-gated, inwardly rectifying K+ channel (known as KGA or GIRK1), application of [D-Ala2,MePhe4,Glyol5]enkephalin) a mu opioid agonist, evoked a dose-dependent increase in K+ conductance. With sustained agonist exposure, the amplitude of the response decayed with a t1/2 of 8 +/- 2 min. In oocytes coexpressing the mu and 5HT1A receptors with GIRK1, stimulation of either receptor resulted in heterologous desensitization of the subsequent response to the other. Injection of guanosine 5'-O-(thiotriphosphate) (1 mM) increased the basal GIRK1 activity and the total response to the application of agonist, but did not affect the rate of desensitization. Basal channel activity in the absence of agonist also desensitized at the same rate when the oocytes were exposed to high K+ (96 mM) solution. The above results indicate that the desensitization of the response occurred at a site downstream of the receptor, possibly at the channel. The rate of desensitization was not significantly altered by any of the following treatments: removal of external Ca2+, preloading the oocytes with 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-tetra-(acetoxymethyl)-ester (0.5-1 mM), elevation of cAMP levels, treatment with phorbol esters (1 microM), staurosporine (0.5 microM), okadaic acid (1 microM), or cytochalasin B (0.5 microM). These results suggest that desensitization may not involve a calcium or phosphorylation-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7822283     DOI: 10.1074/jbc.270.2.589

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Evidence of elevated intracellular calcium levels in weaver homozygote mice.

Authors:  A B Harkins; S Dlouhy; B Ghetti; A L Cahill; L Won; B Heller; A Heller; A P Fox
Journal:  J Physiol       Date:  2000-04-15       Impact factor: 5.182

Review 2.  Mu-opioid receptor desensitization: is morphine different?

Authors:  Mark Connor; Peregrine B Osborne; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

3.  gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5.

Authors:  N Madani; S L Kozak; M P Kavanaugh; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

Review 4.  Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides.

Authors:  B L Kieffer
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

5.  [35S]GTP gamma S binding: a tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells.

Authors:  K Befort; L Tabbara; B L Kieffer
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

6.  Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain.

Authors:  Y J Liao; Y N Jan; L Y Jan
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

7.  Effects of sigma ligands on the cloned mu-, delta- and kappa-opioid receptors co-expressed with G-protein-activated K+ (GIRK) channel in Xenopus oocytes.

Authors:  T Kobayashi; K Ikeda; T Ichikawa; S Togashi; T Kumanishi
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

8.  Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine.

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2010-03-10       Impact factor: 7.853

9.  Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist.

Authors:  Terry Luk; Wenzhen Jin; Alexander Zvonok; Dai Lu; Xin-Zhong Lin; Charles Chavkin; Alexandros Makriyannis; Ken Mackie
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

10.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.